Share on LinkedInShare on LinkedIn

ARTICLE · 14 JULY 2016

Ban On Sharapova

LexCounsel
LexCounsel
Contributor
LexCounsel

LexCounsel

LexCounsel is a New Delhi-based full service law firm with an office in Bhubaneswar and associate...

View firm profile
Explore more from LexCounsel

One of the most shocking news during the recent times for sports fans and legal fraternity, around the globe, has been Maria Sharapova's admittance towards using the banned endurance-enhancing drug known as ‘Meldonium'.

IndiaMedia, Telecoms, IT, Entertainment

One of the most shocking news during the recent times for sports fans and legal fraternity, around the globe, has been Maria Sharapova's admittance towards using the banned endurance-enhancing drug known as 'Meldonium' [added to the World Anti-Doping Agency ("WADA") Prohibited List with effect from January 1, 2016]. The Independent Tribunal ("Tribunal") appointed by the International Tennis Federation ("ITF") [constituted under the rules of the Tennis Anti-Doping Programme 2016 ("TADP")], has imposed a ban on Sharapova for a period of 2 years for committing an anti-doping rule violation under article 2.1 of the TADP, vide its decision dated June 6, 2016.

Below is a detailed analysis of the facts, key issues, arguments before the Tribunal and its findings:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from